Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn Clinical Gastroenterology and Hepatology Volume 14, Issue 11, Pages 1647-1656.e6 (November 2016) DOI: 10.1016/j.cgh.2016.05.039 Copyright © 2016 AGA Institute Terms and Conditions
Figure 1 Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between those with LS value ≤13 kPa and with LS value >13 kPa (both P < .001). Clinical Gastroenterology and Hepatology 2016 14, 1647-1656.e6DOI: (10.1016/j.cgh.2016.05.039) Copyright © 2016 AGA Institute Terms and Conditions
Figure 2 Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between 2 groups in the entire population (both P > .05). Clinical Gastroenterology and Hepatology 2016 14, 1647-1656.e6DOI: (10.1016/j.cgh.2016.05.039) Copyright © 2016 AGA Institute Terms and Conditions
Figure 3 Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between 2 groups using PSM-1 and risks of HCC (C) and LRE (D) between 2 groups using PSM-2 (all P > .05). Clinical Gastroenterology and Hepatology 2016 14, 1647-1656.e6DOI: (10.1016/j.cgh.2016.05.039) Copyright © 2016 AGA Institute Terms and Conditions
Supplementary Figure 1 Kaplan-Meier curves comparing risk of HCC (A) and LRE (B) among LAM group without genotypic resistance, LAM group with rescue therapy, and ETV group (all P > .05). Clinical Gastroenterology and Hepatology 2016 14, 1647-1656.e6DOI: (10.1016/j.cgh.2016.05.039) Copyright © 2016 AGA Institute Terms and Conditions
Supplementary Figure 2 Analysis in patients with LS value ≤13 kPa; Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between two groups, risks of HCC (C) and LRE (D) between two groups using PSM-1, and risks of HCC (E) and LRE (F) between two groups using PSM-2 (all P > .05). Clinical Gastroenterology and Hepatology 2016 14, 1647-1656.e6DOI: (10.1016/j.cgh.2016.05.039) Copyright © 2016 AGA Institute Terms and Conditions
Supplementary Figure 3 Analysis in patients with LS value >13 kPa; Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between two groups, risks of HCC (C) and LRE (D) between two groups using PSM-1, and risks of HCC (E) and LRE (F) between two groups using PSM-2 (all P > .05). Clinical Gastroenterology and Hepatology 2016 14, 1647-1656.e6DOI: (10.1016/j.cgh.2016.05.039) Copyright © 2016 AGA Institute Terms and Conditions
Supplementary Figure 4 Analysis in patients with LS value ≤8 kPa; Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between two groups, risks of HCC (C) and LRE (D) between two groups using PSM-1, and risks of HCC (E) and LRE (F) between two groups using PSM-2 (all P > .05). Clinical Gastroenterology and Hepatology 2016 14, 1647-1656.e6DOI: (10.1016/j.cgh.2016.05.039) Copyright © 2016 AGA Institute Terms and Conditions
Supplementary Figure 5 Analysis in patients with 8 kPa <LS value ≤13 kPa; Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between two groups, risks of HCC (C) and LRE (D) between two groups using PSM-1, and risks of HCC (E) and LRE (F) between two groups using PSM-2 (all P > .05). Clinical Gastroenterology and Hepatology 2016 14, 1647-1656.e6DOI: (10.1016/j.cgh.2016.05.039) Copyright © 2016 AGA Institute Terms and Conditions